B.O.S.S. Retirement Advisors LLC Makes New $881,000 Investment in Masimo Co. (NASDAQ:MASI)

B.O.S.S. Retirement Advisors LLC purchased a new stake in Masimo Co. (NASDAQ:MASI - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,332 shares of the medical equipment provider's stock, valued at approximately $881,000.

Several other hedge funds also recently modified their holdings of MASI. NBC Securities Inc. raised its stake in shares of Masimo by 47.1% during the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 73 shares during the last quarter. UMB Bank n.a. increased its holdings in Masimo by 180.9% in the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 123 shares during the period. Trust Co. of Vermont bought a new position in Masimo during the 4th quarter worth $33,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Masimo by 133.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock worth $44,000 after buying an additional 200 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider's stock valued at $77,000 after acquiring an additional 269 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company's stock.

Analysts Set New Price Targets

MASI has been the subject of several recent analyst reports. Raymond James increased their price objective on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, December 27th. BTIG Research increased their price target on Masimo from $166.00 to $170.00 and gave the stock a "buy" rating in a report on Monday, October 14th. Piper Sandler boosted their price objective on Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, December 18th. Wells Fargo & Company raised their target price on Masimo from $171.00 to $193.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 11th. Finally, Stifel Nicolaus reissued a "buy" rating and issued a $190.00 price target (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $179.67.

Masimo Stock Up 1.3 %

Shares of NASDAQ:MASI traded up $2.16 during trading on Friday, reaching $170.24. 337,899 shares of the stock were exchanged, compared to its average volume of 419,156. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $180.97. The stock has a fifty day moving average of $170.32 and a two-hundred day moving average of $142.15. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The firm has a market cap of $9.11 billion, a price-to-earnings ratio of 117.41 and a beta of 1.01.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. The business's revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.63 earnings per share. Research analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.